308 related articles for article (PubMed ID: 15373890)
21. The role of voriconazole in the treatment of central nervous system blastomycosis.
Ta M; Flowers SA; Rogers PD
Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.
Marbello L; Nosari A; Carrafiello G; Anghilieri M; Cesana C; Cafro AM; D'Avanzo G; Morra E
Haematologica; 2003 Mar; 88(3):ECR05. PubMed ID: 12651283
[No Abstract] [Full Text] [Related]
23. Combined therapy in treatment of murine infection by Fusarium solani.
Ruíz-Cendoya M; Mariné M; Guarro J
J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
[TBL] [Abstract][Full Text] [Related]
24. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Elter T; Sieniawski M; Gossmann A; Wickenhauser C; Schröder U; Seifert H; Kuchta J; Burhenne J; Riedel KD; Fätkenheuer G; Cornely OA
Int J Antimicrob Agents; 2006 Sep; 28(3):262-5. PubMed ID: 16908120
[TBL] [Abstract][Full Text] [Related]
25. Update on the treatment of cerebral aspergillosis.
Schwartz S; Thiel E
Ann Hematol; 2004; 83 Suppl 1():S42-4. PubMed ID: 15124667
[TBL] [Abstract][Full Text] [Related]
26. Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
Bethell D; Hall G; Goodman TR; Klein N; Pollard AJ
J Pediatr Hematol Oncol; 2004 May; 26(5):304-7. PubMed ID: 15111783
[TBL] [Abstract][Full Text] [Related]
27. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Wingard JR; Herbrecht R; Mauskopf J; Schlamm HT; Marciniak A; Roberts CS
Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
[TBL] [Abstract][Full Text] [Related]
28. Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid.
Hiraga A; Uzawa A; Shibuya M; Numata T; Sunami S; Kamitsukasa I
Intern Med; 2009; 48(14):1225-9. PubMed ID: 19602790
[TBL] [Abstract][Full Text] [Related]
29. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
30. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
[TBL] [Abstract][Full Text] [Related]
31. Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Hoenigl M; Krause R
Curr Pharm Des; 2013; 19(20):3648-68. PubMed ID: 23278539
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
[TBL] [Abstract][Full Text] [Related]
33. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Panicker J; Walsh T; Kamani N
Pediatr Infect Dis J; 2006 Apr; 25(4):377-9. PubMed ID: 16567998
[TBL] [Abstract][Full Text] [Related]
34. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
Queiroz-Telles F; Goldani LZ; Schlamm HT; Goodrich JM; Espinel-Ingroff A; Shikanai-Yasuda MA
Clin Infect Dis; 2007 Dec; 45(11):1462-9. PubMed ID: 17990229
[TBL] [Abstract][Full Text] [Related]
35. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
[TBL] [Abstract][Full Text] [Related]
36. Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit.
Nataloni S; Gabbanelli V; Rossi R; Donati A; Pantanetti S; Pelaia P
Minerva Anestesiol; 2007 Jun; 73(6):371-5. PubMed ID: 17072284
[TBL] [Abstract][Full Text] [Related]
37. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
38. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Kohler S; Gerlach U; Guckelberger O; Sauer IM; Jörres D; Neuhaus P; Pratschke J; Pascher A
Transpl Int; 2009 May; 22(5):589-91. PubMed ID: 19175558
[No Abstract] [Full Text] [Related]
40. Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Herbrecht R
Ann Hematol; 2002; 81 Suppl 2():S52-3. PubMed ID: 12611078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
